NIDDM in the cat: treatment with the oral hypoglycemic medication, glipizide.

Author: FordS L

Paper Details 
Original Abstract of the Article :
The oral hypoglycemic medication, glipizide, provides a viable therapeutic alternative to conventional insulin therapy with a positive therapeutic response in approximately 50% of diabetic cats with non-insulin-dependent disease. Response to glipizide therapy or lack thereof usually is evident withi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s0195-5616(95)50056-7

データ提供:米国国立医学図書館(NLM)

Glipizide: A New Hope for Diabetic Cats

Diabetes in [cats] can be a challenging condition to manage. This research investigates the [efficacy of glipizide] in treating [non-insulin-dependent diabetes mellitus (NIDDM)] in [cats]. The authors conducted a [clinical study] to evaluate the [therapeutic response] of [cats with NIDDM] to [glipizide therapy]. Their findings demonstrate that [glipizide] can be a [viable alternative to insulin therapy] for [a significant proportion of diabetic cats]. This study provides valuable insights into the [management of feline diabetes].

Exploring Treatment Options for Feline Diabetes

The study's findings suggest that [glipizide] may be a [useful tool] for [veterinarians] treating [feline NIDDM]. The authors emphasize the importance of [assessing beta cell function] to determine [the potential for response] to [glipizide therapy]. This research highlights the need for [ongoing research] to [develop more effective treatments] for [feline diabetes].

Improving the Well-being of Diabetic Cats

This study provides valuable information for [cat owners] seeking to [manage their cat's diabetes]. The authors suggest that [glipizide] may offer [a promising treatment option] for [cats with NIDDM]. This research underscores the importance of [working closely with veterinarians] to [develop the most effective treatment plan] for [diabetic cats].

Dr.Camel's Conclusion

Just as a camel adapts to its desert environment, diabetic cats require careful management to thrive. This study sheds light on the potential of glipizide as a valuable alternative to insulin therapy for feline diabetes. The findings inspire continued research to develop more effective treatments for diabetic cats, improving their well-being and quality of life.

Date :
  1. Date Completed 1995-10-05
  2. Date Revised 2019-09-13
Further Info :

Pubmed ID

7660535

DOI: Digital Object Identifier

10.1016/s0195-5616(95)50056-7

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.